Adipose stress-sensing kinases: linking obesity to malfunction

Trends in Endocrinology and Metabolism

Volumn 18, Issue 8, 2007, Pages 291-299

  Rudich, Assaf ^a,b   Kanety, Hannah ^c   Bashan, Nava ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b S Daniel Abraham International Center for Health and Nutrition   (Israel)

^c SHEBA MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHOTRANSFERASE;

ADIPOCYTE; ADIPOSE TISSUE; ENDOCRINE DISEASE; ENDOPLASMIC RETICULUM; INFLAMMATION; METABOLIC DISORDER; NONHUMAN; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW;

ADIPOSE TISSUE; ANIMALS; HUMANS; HYPERTROPHY; INFLAMMATION; MODELS, BIOLOGICAL; OBESITY; OXIDATIVE STRESS; PHOSPHOTRANSFERASES; SIGNAL TRANSDUCTION; STRESS, PHYSIOLOGICAL;

EID: 34948911181     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tem.2007.08.006     Document Type: Review

References (72)

1. Selye H. A syndrome produced by diverse nocuous agents. Nature 138 (1936) 230-231
2. Rudich A., and Bashan N. Cellular redox state and insulin sensitivity: potential role of lipoic acid. In: Zierath J.R., and Wallberg-Henriksen H. (Eds). Muscle Metabolism (2002), Taylor and Francis 329-348
3. Monnier L., et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with Type 2 diabetes. J. Am. Med. Assoc. 295 (2006) 1681-1687
4. Furukawa S., et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J. Clin. Invest. 114 (2004) 1752-1761
5. Talior I., et al. PKC-δ-dependent activation of oxidative stress in adipocytes of obese and insulin-resistant mice: role for NADPH oxidase. Am. J. Physiol. Endocrinol. Metab. 288 (2005) E405-E411
6. Park J., et al. Overexpression of glucose-6-phosphate dehydrogenase is associated with lipid dysregulation and insulin resistance in obesity. Mol. Cell. Biol. 25 (2005) 5146-5157
7. Galinier A., et al. Adipose tissue proadipogenic redox changes in obesity. J. Biol. Chem. 281 (2006) 12682-12687
8. Grimsrud P.A., et al. Carbonylation of adipose proteins in obesity and insulin resistance: identification of adipocyte fatty acid-binding protein as a cellular target of 4-hydroxynonenal. Mol. Cell. Proteomics 6 (2007) 624-637
9. Cancello R., et al. Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity. Diabetes 55 (2006) 1554-1561
10. Harman-Boehm I., et al. Macrophage infiltration into omental versus subcutaneous fat across different populations: effect of regional adiposity and the co-morbidities of obesity. J. Clin. Endocrinol. Metab. 92 (2007) 2240-2247
11. Weisberg S.P., et al. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112 (2003) 1796-1808
12. Xu H., et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 112 (2003) 1821-1830
13. Lumeng C.N., et al. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J. Clin. Invest. 117 (2007) 175-184
14. Summers S.A. Ceramides in insulin resistance and lipotoxicity. Prog. Lipid Res. 45 (2006) 42-72
15. Delarue J., and Magnan C. Free fatty acids and insulin resistance. Curr. Opin. Clin. Nutr. Metab. Care 10 (2007) 142-148
16. Hazel M., et al. Activation of the hexosamine signaling pathway in adipose tissue results in decreased serum adiponectin and skeletal muscle insulin resistance. Endocrinology 145 (2004) 2118-2128
17. Pouwels M.J., et al. Role of hexosamines in insulin resistance and nutrient sensing in human adipose and muscle tissue. J. Clin. Endocrinol. Metab. 89 (2004) 5132-5137
18. Lin Y., et al. The hyperglycemia-induced inflammatory response in adipocytes: the role of reactive oxygen species. J. Biol. Chem. 280 (2005) 4617-4626
19. Samad F., et al. Altered adipose and plasma sphingolipid metabolism in obesity: a potential mechanism for cardiovascular and metabolic risk. Diabetes 55 (2006) 2579-2587
20. Chavez J.A., and Summers S.A. Characterizing the effects of saturated fatty acids on insulin signaling and ceramide and diacylglycerol accumulation in 3T3-L1 adipocytes and C2C12 myotubes. Arch. Biochem. Biophys. 419 (2003) 101-109
21. Lundgren M., and Eriksson J.W. No in vitro effects of fatty acids on glucose uptake, lipolysis or insulin signaling in rat adipocytes. Horm. Metab. Res. 36 (2004) 203-209
22. Nguyen M.T., et al. JNK and tumor necrosis factor-α mediate free fatty acid-induced insulin resistance in 3T3-L1 adipocytes. J. Biol. Chem. 280 (2005) 35361-35371
23. Suganami T., et al. A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor α. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 2062-2068
24. Shi H., et al. TLR4 links innate immunity and fatty acid-induced insulin resistance. J. Clin. Invest. 116 (2006) 3015-3025
25. Ozcan U., et al. Endoplasmic reticulum stress links obesity, insulin action, and Type 2 diabetes. Science 306 (2004) 457-461
26. Hosogai N., et al. Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes 56 (2007) 901-911
27. Hotamisligil G.S. Inflammation and metabolic disorders. Nature 444 (2006) 860-867
28. Cinti S., et al. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J. Lipid Res. 46 (2005) 2347-2355
29. DiGirolamo M., et al. Qualitative regional differences in adipose tissue growth and cellularity in male Wistar rats fed ad libitum. Am. J. Physiol. 274 (1998) R1460-R1467
30. Suganami T., et al. Role of the Toll-like receptor 4/NF-κB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages. Arterioscler. Thromb. Vasc. Biol. 27 (2007) 84-91
31. Chevillotte E., et al. Uncoupling protein 2 controls adiponectin gene expression in adipose tissue through the modulation of reactive oxygen species production. Diabetes 56 (2007) 1042-1050
32. Scott J.A., and King G.L. Oxidative stress and antioxidant treatment in diabetes. Ann. N. Y. Acad. Sci. 1031 (2004) 204-213
33. Karin M. Inflammation-activated protein kinases as targets for drug development. Proc. Am. Thorac. Soc. 2 (2005) 386-390
34. Tsang C.K., et al. Targeting mammalian target of rapamycin (mTOR) for health and diseases. Drug Discov. Today 12 (2007) 112-124
35. Weston C.R., and Davis R.J. The JNK signal transduction pathway. Curr. Opin. Cell Biol. 19 (2007) 142-149
36. Wellen K.E., and Hotamisligil G.S. Inflammation, stress, and diabetes. J. Clin. Invest. 115 (2005) 1111-1119
37. Carlson C.J., et al. Enhanced basal activation of mitogen-activated protein kinases in adipocytes from type 2 diabetes: potential role of p38 in the downregulation of GLUT4 expression. Diabetes 52 (2003) 634-641
38. Nagai H., et al. Pathophysiological roles of ASK1-MAP kinase signaling pathways. J. Biochem. Mol. Biol. 40 (2007) 1-6
39. Tang X., et al. An RNA interference-based screen identifies MAP4K4/NIK as a negative regulator of PPARγ, adipogenesis, and insulin-responsive hexose transport. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 2087-2092
40. Zick Y. Ser/Thr phosphorylation of IRS proteins: a molecular basis for insulin resistance. Sci. STKE 2005 (2005) pe4
41. Fujishiro M., et al. Three mitogen-activated protein kinases inhibit insulin signaling by different mechanisms in 3T3-L1 adipocytes. Mol. Endocrinol. 17 (2003) 487-497
42. Carlson C.J., and Rondinone C.M. Pharmacological inhibition of p38 MAP kinase results in improved glucose uptake in insulin-resistant 3T3-L1 adipocytes. Metabolism 54 (2005) 895-901
43. Gao Z., et al. Inhibition of insulin sensitivity by free fatty acids requires activation of multiple serine kinases in 3T3-L1 adipocytes. Mol. Endocrinol. 18 (2004) 2024-2034
44. Haruta T., et al. A rapamycin-sensitive pathway down-regulates insulin signaling via phosphorylation and proteasomal degradation of insulin receptor substrate-1. Mol. Endocrinol. 14 (2000) 783-794
45. Yuan M., et al. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkβ. Science 293 (2001) 1673-1677
46. Hernandez R., et al. Rosiglitazone ameliorates insulin resistance in brown adipocytes of Wistar rats by impairing TNF-α induction of p38 and p42/p44 mitogen-activated protein kinases. Diabetologia 47 (2004) 1615-1624
47. Kim K.Y., et al. c-Jun N-terminal kinase is involved in the suppression of adiponectin expression by TNF-α in 3T3-L1 adipocytes. Biochem. Biophys. Res. Commun. 327 (2005) 460-467
48. Rohl M., et al. Conditional disruption of IκB kinase 2 fails to prevent obesity-induced insulin resistance. J. Clin. Invest. 113 (2004) 474-481
49. Kim J.K., et al. Prevention of fat-induced insulin resistance by salicylate. J. Clin. Invest. 108 (2001) 437-446
50. Ozcan U., et al. Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of Type 2 diabetes. Science 313 (2006) 1137-1140
51. Hirosumi J., et al. A central role for JNK in obesity and insulin resistance. Nature 420 (2002) 333-336
52. Jaeschke A., et al. An essential role of the JIP1 scaffold protein for JNK activation in adipose tissue. Genes Dev. 18 (2004) 1976-1980
53. Prada P.O., et al. Western diet modulates insulin signaling, c-Jun N-terminal kinase activity, and insulin receptor substrate-1ser307 phosphorylation in a tissue-specific fashion. Endocrinology 146 (2005) 1576-1587
54. Jiang G., et al. Rosiglitazone, an agonist of peroxisome-proliferator-activated receptor gamma (PPARγ), decreases inhibitory serine phosphorylation of IRS1 in vitro and in vivo. Biochem. J. 377 (2004) 339-346
55. Um S.H., et al. Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity. Nature 431 (2004) 200-205
56. Le Bacquer O., et al. Elevated sensitivity to diet-induced obesity and insulin resistance in mice lacking 4E-BP1 and 4E-BP2. J. Clin. Invest. 117 (2007) 387-396
57. Rui L. A link between protein translation and body weight. J. Clin. Invest. 117 (2007) 310-313
58. Bashan N., et al. MAP kinases, IKK and insulin signaling in human omental versus subcutaneous adipose tissue in obesity. Endocrinology 148 (2007) 2955-2962
59. Lappas M., et al. Sulfasalazine and BAY 11-7082 interfere with the nuclear factor-κB and IκB kinase pathway to regulate the release of proinflammatory cytokines from human adipose tissue and skeletal muscle in vitro. Endocrinology 146 (2005) 1491-1497
60. Liu G., and Rondinone C.M. JNK: bridging the insulin signaling and inflammatory pathway. Curr. Opin. Investig. Drugs 6 (2005) 979-987
61. Kaneto H., et al. Possible novel therapy for diabetes with cell-permeable JNK-inhibitory peptide. Nat. Med. 10 (2004) 1128-1132
62. Lee Y.H., et al. c-Jun N-terminal kinase (JNK) mediates feedback inhibition of the insulin signaling cascade. J. Biol. Chem. 278 (2003) 2896-2902
63. Evans J.L., et al. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of Type 2 diabetes. Endocr. Rev. 23 (2002) 599-622
64. Aouadi M., et al. Role of MAPKs in development and differentiation: lessons from knockout mice. Biochimie 88 (2006) 1091-1098
65. Jager J., et al. Interleukin-1β-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression. Endocrinology 148 (2007) 241-251
66. Bost F., et al. The extracellular signal-regulated kinase isoform ERK1 is specifically required for in vitro and in vivo adipogenesis. Diabetes 54 (2005) 402-411
67. Engelman J.A., et al. Tumor necrosis factor α-mediated insulin resistance, but not dedifferentiation, is abrogated by MEK1/2 inhibitors in 3T3-L1 adipocytes. Mol. Endocrinol. 14 (2000) 1557-1569
68. Gao Z., et al. Aspirin inhibits serine phosphorylation of insulin receptor substrate 1 in tumor necrosis factor-treated cells through targeting multiple serine kinases. J. Biol. Chem. 278 (2003) 24944-24950
69. Carlson C.J., et al. Mammalian target of rapamycin regulates IRS-1 serine 307 phosphorylation. Biochem. Biophys. Res. Commun. 316 (2004) 533-539
70. Tzatsos A., and Kandror K.V. Nutrients suppress phosphatidylinositol 3-kinase/Akt signaling via raptor-dependent mTOR-mediated insulin receptor substrate 1 phosphorylation. Mol. Cell. Biol. 26 (2006) 63-76
71. Tremblay F., et al. Activation of the mammalian target of rapamycin pathway acutely inhibits insulin signaling to Akt and glucose transport in 3T3-L1 and human adipocytes. Endocrinology 146 (2005) 1328-1337
72. Kim J.K., et al. PKC-theta knockout mice are protected from fat-induced insulin resistance. J. Clin. Invest. 114 (2004) 823-827